Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress GlobeNewswire - Thu Nov 7, 6:30AM CST

NTLA : 16.00 (-0.37%)
Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day? Motley Fool - Wed Nov 6, 8:45AM CST

There's nothing bearish at all about what it reported recently.

NTLA : 16.00 (-0.37%)
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Nov 5, 3:01PM CST

NTLA : 16.00 (-0.37%)
This Beaten-Down Stock Could Soar by 354%, According to Wall Street Motley Fool - Mon Nov 4, 7:00AM CST

Maybe the Street is a bit too optimistic on this one.

NTLA : 16.00 (-0.37%)
Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024 GlobeNewswire - Thu Oct 31, 6:30AM CDT

NTLA : 16.00 (-0.37%)
12 High-Growth Stocks That Could Deliver Parabolic Returns Motley Fool - Mon Oct 28, 9:00AM CDT

These 12 innovative companies could deliver exponential returns over the next quarter century.

NVDA : 148.88 (+2.24%)
NVTS : 2.20 (-4.35%)
VRTX : 502.45 (+1.78%)
RKLB : 13.46 (+3.14%)
LUNR : 9.52 (+15.25%)
SERV : 10.83 (+7.33%)
ACHR : 3.50 (+9.03%)
TSLA : 296.91 (+2.90%)
CRSP : 51.88 (+2.29%)
SOUN : 6.95 (+22.14%)
APLD : 7.79 (+10.18%)
TM : 178.45 (+1.88%)
Why Intellia Therapeutics Stock Plummeted by 20% Today Motley Fool - Thu Oct 24, 6:22PM CDT

Seemingly encouraging results from the lab were met with some notable skepticism.

NTLA : 16.00 (-0.37%)
Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE) GlobeNewswire - Thu Oct 24, 7:01AM CDT

NTLA : 16.00 (-0.37%)
This Beaten-Down Growth Stock Could Skyrocket 234%, According to Wall Street Motley Fool - Thu Oct 17, 5:30AM CDT

Intellia Therapeutics' innovative gene editing technology could revolutionize medicine, but investors need a strong stomach for volatility.

NTLA : 16.00 (-0.37%)
Intellia Therapeutics Announces New Date for Upcoming Investor Webcast GlobeNewswire - Thu Oct 10, 6:30AM CDT

NTLA : 16.00 (-0.37%)

Barchart Exclusives

Up 160% in 3 Months, Is It Too Late to Buy Astera Labs Stock? Barchart - 17 minutes ago
Breakout semiconductor stock ALAB has more than doubled in just a few months. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot